December 20, 2024

Will CAR T-Cell Therapy Be the Magic Bullet for My Multiple Myeloma?

“Intense pain on the right side of my lower rib cage, in 2020, sent me first to my chiropractor for relief and then to my primary care provider for tests. Because of the location of the pain, the chir...

The ASCO Post

December 20, 2024

Courts, Congress keep Corporate Transparency Act in flux

Dentists potentially impacted by the CTA are receiving mixed messages about whether they need to file for beneficial ownership.

ADA News

December 20, 2024

Riluzole Shows Promise in Reversing Cognitive Decline from Radiation Therapy

Boosting brain-derived neurotrophic factor (BDNF) with riluzole may mitigate cognitive dysfunction from radiation therapy.

Conexiant

December 20, 2024

Epcoritamab Monotherapy for Pretreated Relapsed or Refractory CLL

In the ongoing EPCORE CLL-1 trial, monotherapy with the biologic agent epcoritamab offered benefit in some heavily pretreated patients with resistant chronic lymphocytic leukemia, supporting its conti...

The ASCO Post

December 20, 2024

Study Finds Daratumumab Monotherapy Prevented or Delayed Progression From Smoldering to Active Multiple Myeloma

The ongoing randomized phase III AQUILA study found that daratumumab monotherapy was well tolerated and demonstrated a clinically meaningful and significant benefit in preventing or delaying progressi...

The ASCO Post

December 20, 2024

Bio-interventional Cyclodialysis with Allograft Scleral Reinforcement for OAG

The combined procedure decreased IOP and improved BCVA.

Conexiant

December 20, 2024

Empagliflozin Reduces Risk of Diabetic Retinopathy Progression

Investigators found a 22% reduced risk of progression in patients with preexisting NPDR.

Conexiant

December 20, 2024

In Treatment of Transplant-Ineligible Myeloma, Addition of Isatuximab Improves Outcomes

In the phase III IMROZ trial, the addition of the anti-CD38 monoclonal antibody isatuximab-irfc to bortezomib, lenalidomide, and dexamethasone (VRd) was more effective than VRd alone as initial therap...

The ASCO Post

December 20, 2024

Annual Code Maintenance Committee meeting to take place in March 2025

The committee will vote to accept, amend or decline CDT Code changes for 2026.

ADA News